New drug is gamechanger in psoriasis treatment

A novel drug almost entirely cleared moderate to severe psoriasis in over 60% of the patients who took part in two phase three clinical trials of a new drug.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *